CIK 0001904286 · <br>Emerging growth company
MIRA PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MIRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- Incorporated
- FL
- Entity type
- operating
- EIN
- 853354547
- Phone
- 813-369-5150
- Business address
- 1200 BRICKELL AVENUE, SUITE 1950 #1183, MIAMI, FL, 33131
- Former names
- Mira1a Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-12 | Whalen Matthew Pratt Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2026-06-12 | Shekhat Denil Nanji Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2026-06-12 | MacPherson Edward Clouston Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2026-06-12 | Del Giudice Matthew Paul Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2026-03-30 | Aminov Erez Chief Executive Officer | Grant or award · Restricted Stock Units | +83,500 | 83,500 | ||
| 2025-10-01 | Shekhat Denil Nanji Director | Grant or award | +22,378 | $1.35 | $30K | 22,378 |
| 2025-10-01 | Aminov Erez Chief Executive Officer | Grant or award | +2,685,456 | 3,530,156 | ||
| 2025-09-18 | Aminov Erez Chief Executive Officer | Grant or award · Stock Options (right to buy) 10b5-1 | +150,000 | 150,000 | ||
| 2025-09-18 | Aminov Erez Chief Executive Officer | Grant or award · Stock Options (right to buy) 10b5-1 | +150,000 | 150,000 | ||
| 2025-08-29 | Aminov Erez Chief Executive Officer | Grant or award | +62,500 | $1.37 | $86K | 844,700 |
| 2024-12-09 | Yanez Michelle Chief Financial Officer | Grant or award · Stock Options (right to buy) | +150,000 | 150,000 | ||
| 2024-12-09 | Whalen Matthew Pratt Director | Grant or award · Stock Options (right to buy) | +25,000 | 25,000 | ||
| 2024-12-09 | Shekhat Denil Nanji Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2024-12-09 | MacPherson Edward Clouston Director | Grant or award · Stock Options (right to buy) | +25,000 | 25,000 | ||
| 2024-12-09 | Del Giudice Matthew Paul Director | Grant or award · Stock Options (right to buy) | +25,000 | 75,000 | ||
| 2024-12-09 | Aminov Erez Chief Executive Officer | Grant or award · Stock Options (right to buy) | +2,000,000 | 2,000,000 | ||
| 2024-12-09 | Aminov Erez Chief Executive Officer | Grant or award · Restricted Stock Units | +500,000 | 500,000 | ||
| 2024-11-20 | Aminov Erez Chief Executive Officer | Sale 10b5-1 | −44,590 | $1.27 | $57K | 1,061,200 |
| 2024-11-19 | Aminov Erez Chief Executive Officer | Sale 10b5-1 | −55,410 | $1.39 | $77K | 1,105,790 |
| 2024-08-28 | McNulty Brian Patrick 10% owner | Sale | −200,000 | $1.96 | $392K | 2,540,270 |
Page 1 of 4 · 65 trades